Cerus Corporation's INTERCEPT Platelet Processing Sets' shelf life extended to 12 months by FDA.
Cerus Corporation receives FDA approval to extend its INTERCEPT Platelet Processing Sets' shelf life to 12 months, up from the previous 6 months. The extension benefits customers and supply chains by enabling more effective inventory management. Cerus is generating data for potential further shelf life extension beyond 12 months, while its INTERCEPT Blood System is globally available for platelets and plasma.
March 26, 2024
3 Articles